Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2017

Open Access 01-12-2017 | Short report

History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA

Authors: Maria Luisa Mittal, Devesh Vashishtha, Shelly Sun, Sonia Jain, Jazmine Cuevas-Mota, Richard Garfein, Steffanie A. Strathdee, Dan Werb

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2017

Login to get access

Abstract

Background

Medication-assisted treatment (MAT) remains the gold standard for the treatment of opioid use disorder. MAT also reduces the frequency of injecting among people who inject drugs (PWID). Relatedly, data suggest that PWID play a key role in the initiation of others into drug injecting by exposing injecting practices to injection-naïve drug users. Our primary objective was to test whether a history of MAT enrollment is associated with a reduced odds of PWID providing injection initiation assistance.

Methods

Preventing Injecting by Modifying Existing Responses (PRIMER; NIDA DP2-DA040256–01), is a multi-site cohort study assessing the impact of socio-structural factors on the risk that PWID provide injection initiation assistance. Data were drawn from a participating cohort of PWID in San Diego, CA. The primary outcome was reporting ever providing injection initiation assistance; the primary predictor was reporting ever being enrolled in MAT. Logistic regression was used to model associations between MAT enrollment and ever initiating others into injecting while adjusting for potential confounders.

Results

Participants (n = 354) were predominantly male (n = 249, 70%). Thirty-eight percent (n = 135) of participants reported ever initiating others into injection drug use. In multivariate analysis, participants who reported a history of MAT enrollment had significantly decreased odds of ever providing injection initiation assistance (Adjusted Odds Ratio [AOR]: 0.62, 95% Confidence Interval [CI]: 0.39–0.99).

Conclusions

These preliminary findings suggest an association between MAT enrollment and a lower odds that male PWID report providing injection initiation assistance to injection-naïve drug users. Further research is needed to identify the pathways by which MAT enrollment may impact the risk that PWID initiate others into drug injecting.
Literature
3.
go back to reference Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;l8(3):CD002209. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;l8(3):CD002209.
4.
go back to reference Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;10(8):CD004145. Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;10(8):CD004145.
5.
go back to reference Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 Sep 15;13(1):25.CrossRefPubMedPubMedCentral Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 Sep 15;13(1):25.CrossRefPubMedPubMedCentral
6.
go back to reference Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–76.CrossRefPubMed Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–76.CrossRefPubMed
8.
go back to reference Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564–74.CrossRefPubMed Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564–74.CrossRefPubMed
9.
go back to reference Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.CrossRefPubMedPubMedCentral Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86(5):655–61.CrossRefPubMedPubMedCentral
10.
go back to reference Scott N, Caulkins JP, Ritter A, Dietze P. How patterns of injecting drug use evolve in a cohort of people who inject drugs. Trends and Issues in Crime and Criminal Justice. 2015;502:1. Scott N, Caulkins JP, Ritter A, Dietze P. How patterns of injecting drug use evolve in a cohort of people who inject drugs. Trends and Issues in Crime and Criminal Justice. 2015;502:1.
11.
go back to reference Grella CE. From generic to gender-responsive treatment: Changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs. 2008 Nov 1;40(sup5):327–43.CrossRef Grella CE. From generic to gender-responsive treatment: Changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs. 2008 Nov 1;40(sup5):327–43.CrossRef
12.
go back to reference Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67.CrossRefPubMedPubMedCentral Goldsamt LA, Harocopos A, Kobrak P, Jost JJ, Clatts MC. Circumstances, pedagogy and rationales for injection initiation among new drug injectors. J Community Health. 2010;35(3):258–67.CrossRefPubMedPubMedCentral
13.
go back to reference Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Substance Abuse Treatment, Prevention, and Policy. 2009;4(1):1.CrossRef Small W, Fast D, Krusi A, Wood E, Kerr T. Social influences upon injection initiation among street-involved youth in Vancouver, Canada: a qualitative study. Substance Abuse Treatment, Prevention, and Policy. 2009;4(1):1.CrossRef
14.
go back to reference Bryant J, Bryant J, Treloar C, Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug and alcohol review. 2007 Jan 1;26(3):287–93.CrossRefPubMed Bryant J, Bryant J, Treloar C, Bryant J, Treloar C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug and alcohol review. 2007 Jan 1;26(3):287–93.CrossRefPubMed
15.
go back to reference Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77(3):396–414.CrossRefPubMedPubMedCentral Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000;77(3):396–414.CrossRefPubMedPubMedCentral
16.
go back to reference Bluthenthal RN, Wenger L, Chu D, Quinn B, Thing J, Kral AH. Factors associated with initiating someone into illicit drug injection. Drug Alcohol Depend. 2014 Nov 1;144:186–92.CrossRefPubMedPubMedCentral Bluthenthal RN, Wenger L, Chu D, Quinn B, Thing J, Kral AH. Factors associated with initiating someone into illicit drug injection. Drug Alcohol Depend. 2014 Nov 1;144:186–92.CrossRefPubMedPubMedCentral
17.
go back to reference Bryant J, Treloar C. Initiators: An examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008 Nov 1;12(6):885–90.CrossRefPubMed Bryant J, Treloar C. Initiators: An examination of young injecting drug users who initiate others to injecting. AIDS Behav. 2008 Nov 1;12(6):885–90.CrossRefPubMed
18.
go back to reference Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2–3):145–52.CrossRefPubMed Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend. 2007;89(2–3):145–52.CrossRefPubMed
19.
go back to reference Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend. 2007 Jan 5;86(1):1–21.CrossRefPubMed Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend. 2007 Jan 5;86(1):1–21.CrossRefPubMed
20.
go back to reference Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abus Treat. 2002 Dec 31;23(4):285–95.CrossRef Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abus Treat. 2002 Dec 31;23(4):285–95.CrossRef
21.
go back to reference Messina N, Grella CE, Cartier J, Torres SA. randomized experimental study of gender-responsive substance abuse treatment for women in prison. J Subst Abus Treat. 2010 Mar 31;38(2):97–107.CrossRef Messina N, Grella CE, Cartier J, Torres SA. randomized experimental study of gender-responsive substance abuse treatment for women in prison. J Subst Abus Treat. 2010 Mar 31;38(2):97–107.CrossRef
22.
go back to reference Jimenez-Treviño L, Saiz PA, García-Portilla MP, Díaz-Mesa EM, Sánchez-Lasheras F, Burón P, et al. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. Addict Behav. 2011;36(12):1184–90.CrossRefPubMed Jimenez-Treviño L, Saiz PA, García-Portilla MP, Díaz-Mesa EM, Sánchez-Lasheras F, Burón P, et al. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences. Addict Behav. 2011;36(12):1184–90.CrossRefPubMed
23.
go back to reference Marsh JC, Cao D, D’Aunno T. Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abus Treat. 2004;27(4):289–300.CrossRef Marsh JC, Cao D, D’Aunno T. Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abus Treat. 2004;27(4):289–300.CrossRef
24.
go back to reference Haug NA, Sorensen J, Lollo N, Gruber V, Delucchi K, Hall S. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005;17(8):1022–9.CrossRefPubMed Haug NA, Sorensen J, Lollo N, Gruber V, Delucchi K, Hall S. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005;17(8):1022–9.CrossRefPubMed
25.
go back to reference Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use & Misuse. 1999;34(8):1137–65.CrossRef Chatham LR, Hiller ML, Rowan-Szal GA, Joe GW, Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use & Misuse. 1999;34(8):1137–65.CrossRef
26.
go back to reference Wenger LD, Lopez AM, Kral AH, Bluthenthal RN. Moral ambivalence and the decision to initiate others into injection drug use: A qualitative study in two California cities. International Journal of Drug Policy. 2016 Nov 30;37:42–51.CrossRefPubMed Wenger LD, Lopez AM, Kral AH, Bluthenthal RN. Moral ambivalence and the decision to initiate others into injection drug use: A qualitative study in two California cities. International Journal of Drug Policy. 2016 Nov 30;37:42–51.CrossRefPubMed
Metadata
Title
History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA
Authors
Maria Luisa Mittal
Devesh Vashishtha
Shelly Sun
Sonia Jain
Jazmine Cuevas-Mota
Richard Garfein
Steffanie A. Strathdee
Dan Werb
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2017
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-017-0126-1

Other articles of this Issue 1/2017

Substance Abuse Treatment, Prevention, and Policy 1/2017 Go to the issue